Enanta Pharmaceuticals, Inc.
NMS: ENTALive Quote
📈 ZcoreAI Score
Our AI model analyzes Enanta Pharmaceuticals, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get ENTA Z-Score →About Enanta Pharmaceuticals, Inc.
Healthcare
Biotechnology
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
📊 Fundamental Analysis
Enanta Pharmaceuticals, Inc. demonstrates a profit margin of -106.8%, which is below the sector average, suggesting competitive pressure.
The company recently reported 9.8% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is -60.0%, which indicates that capital utilization is currently under pressure.
At a current price of $14.11, ENTA currently sits at the 76th percentile of its 52-week range (Range: $4.55 - $17.15).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
⚠️
Revenue Growth
Moderate
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$409.46M
Trailing P/E
--
Forward P/E
-6.39
Beta (5Y)
1.00
52W High
$17.15
52W Low
$4.55
Avg Volume
185K
Day High
Day Low